(Q41679565)

7 October 2017

Incremental cost-effectiveness analysis: the optimal strategy depends on the strategy set. (English)

1 reference

7 October 2017

Cantor SB

1

1 reference

PubMed ID

10408990

7 October 2017

Ganiats TG

series ordinal

2

1 reference

7 October 2017

1 June 1999

1 reference

Journal of Clinical Epidemiology

7 October 2017

1 reference

7 October 2017

52

1 reference

7 October 2017

6

1 reference

7 October 2017

517-522

1 reference

Foundations of Cost-Effectiveness Analysis for Health and Medical Practices

7 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900021-9

7 January 2021

Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900021-9

7 January 2021

The cost-effectiveness of preventing AIDS-related opportunistic infections

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900021-9

7 January 2021

Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900021-9

7 January 2021

Long-term cost-effectiveness of alternative management strategies for patients with life-threatening ventricular arrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring (ESVEM) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900021-9

7 January 2021

Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900021-9

7 January 2021

Cost-effectiveness of a community-level HIV risk reduction intervention.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900021-9

7 January 2021

Strategies for screening for colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900021-9

7 January 2021

Incremental cost-effectiveness of incorporating oestriol evaluation in Down syndrome screening programmes

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900021-9

7 January 2021

Cost-effectiveness analysis, extended dominance, and ethics: a quantitative assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900021-9

7 January 2021

Screening for prostate cancer. A decision analytic view

1 reference

https://api.crossref.org/works/10.1016%2FS0895-4356%2899%2900021-9

7 January 2021

10.1016/S0895-4356(99)00021-9

Identifiers

DOI

1 reference

7 October 2017

1 reference

PubMed ID

10408990